From San Francisco, at a meeting of the Infectious Diseases Society of America
An experimental vaccine against the microbe that causes strep throat can induce a potent immune response in adults, a U.S.–Canadian research team reports. The finding suggests that the vaccine is ready for large-scale testing in adults and children.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.